Cardiac Resynchronisation Therapy (CRT) - Medical Devices Pipeline Assessment, 2018

  • ID: 4544598
  • Report
  • 89 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Boston Scientific Corp
  • EBR Systems Inc
  • Johns Hopkins University
  • Mayo Clinic
  • MicroPort Scientific Corp
  • Odem Medical Ltd
  • MORE
Cardiac Resynchronisation Therapy (CRT) - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Cardiac Resynchronisation Therapy (CRT) - Medical Devices Pipeline Assessment, 2018" provides an overview of Cardiac Resynchronisation Therapy (CRT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Resynchronisation Therapy (CRT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Resynchronisation Therapy (CRT) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Resynchronisation Therapy (CRT) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry.
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Resynchronisation Therapy (CRT) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Boston Scientific Corp
  • EBR Systems Inc
  • Johns Hopkins University
  • Mayo Clinic
  • MicroPort Scientific Corp
  • Odem Medical Ltd
  • MORE
1 Table of Contents

2 Introduction
2.1 Cardiac Resynchronisation Therapy (CRT) Overview

3 Products under Development
3.1 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
3.2 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
3.3 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
3.4 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
3.5 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
3.6 Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials

4 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products under Development by Companies
4.1 Cardiac Resynchronisation Therapy (CRT) Companies - Pipeline Products by Stage of Development
4.2 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development

5 Cardiac Resynchronisation Therapy (CRT) Companies and Product Overview
5.1 AI Medical Semiconductor Ltd. Company Overview
5.1.1 AI Medical Semiconductor Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.2 Boston Scientific Corp Company Overview
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 DHS Medical Company Overview
5.3.1 DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
5.4 EBR Systems Inc Company Overview
5.4.1 EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 IRadimed Corp Company Overview
5.5.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
5.6 Johns Hopkins University Company Overview
5.6.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.7 LivaNova PLC Company Overview
5.7.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Mayo Clinic Company Overview
5.8.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.9 Medtronic plc Company Overview
5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.10 MicroPort Scientific Corp Company Overview
5.10.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.11 NewPace Ltd Company Overview
5.11.1 NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 Odem Medical Ltd Company Overview
5.12.1 Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 St. Jude Medical LLC Company Overview
5.13.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.14 TransWorld Med Corp Company Overview
5.14.1 TransWorld Med Corp Pipeline Products & Ongoing Clinical Trials Overview

6 Cardiac Resynchronisation Therapy (CRT)- Recent Developments
6.1 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.2 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.3 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.4 Apr 03, 2018: Nihon Kohden Announces Change in Representative Director and Director
6.5 Mar 10, 2018: LifeVest Wearable Defibrillator Reduces Total Mortality By 36 Percent At 90 Days
6.6 Mar 07, 2018: EBR Systems Initiates Global Trial of World’s Only Wireless CRT Pacing Technology
6.7 Mar 01, 2018: Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker
6.8 Mar 01, 2018: First BIOTRONIK Pacemakers in Japan Approved for 3 Tesla Full-Body MRIs
6.9 Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results
6.10 Feb 27, 2018: genedrive Receives Significant Funding for TB Test Development
6.11 Feb 26, 2018: Medtronic Recalls Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillators Due to Manufacturing Error Preventing Electrical Shock Delivery
6.12 Feb 26, 2018: Tissue Regenix Group: Launch of TRX BioSurgery and new distributor agreement
6.13 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
6.14 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.15 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.16 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.17 Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development
6.18 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.19 Dec 19, 2017: Bluetooth Pacemakers Offer Convenience and Cost Savings
6.20 Dec 13, 2017: Electric eel inspires new power source
6.21 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.22 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.23 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.24 Nov 02, 2017: Mexican doctors safely reuse donated pacemakers after sterilization
6.25 Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results
6.26 Nov 02, 2017: Nihon Kohden opens a sales branch in Kenya
6.27 Oct 31, 2017: AHA/ACC/HRS Publish New Guidelines on the Wearable Cardioverter Defibrillator for Patients at Risk of Sudden Cardiac Death
6.28 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.29 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.30 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.31 Sep 27, 2017: ZOLL Canada Wins Tender to Equip Province of Quebec Paramedic Services with ZOLL X Series Monitor/Defibrillators
6.32 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.33 Aug 21, 2017: BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
6.34 Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results
6.35 Aug 03, 2017: BIOTRONIK’s Newest CRT-D Device with MultiPole Pacing Now Available in Japan
6.36 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.37 Jul 19, 2017: Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology For Heart Failure Patients
6.38 Jul 13, 2017: Nihon Kohden Selected for FTSE4Good Index Series and FTSE Blossom Japan Index
6.39 Jul 10, 2017: BIOTRONIK’s New Quadripolar CRT-P with More Pacing Options Now Available in Japan
6.40 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.41 Jun 20, 2017: EBR Systems Awarded Favorite Innovation for WiSE CRT at 2017 EHRA Europace Cardiostim Congress
6.42 Jun 13, 2017: Nihon Kohden to reorganize its group companies in India
6.43 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
Table 2: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
Table 3: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
Table 4: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
Table 5: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials
Table 7: Cardiac Resynchronisation Therapy (CRT) Companies - Pipeline Products by Stage of Development
Table 8: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
Table 9: AI Medical Semiconductor Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Adaptive CRT And Vagal Stimulation Device - Product Status
Table 11: Adaptive CRT And Vagal Stimulation Device - Product Description
Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Next Generation Quad Polar CRT-D - Product Status
Table 14: Next Generation Quad Polar CRT-D - Product Description
Table 15: NG3 Non Quad System - Product Status
Table 16: NG3 Non Quad System - Product Description
Table 17: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 18: Next Generation Quad Polar CRT-D - Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
Table 19: DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Drimmer - Product Status
Table 21: Drimmer - Product Description
Table 22: Twistek - Product Status
Table 23: Twistek - Product Description
Table 24: EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Second Generation WiSE CRT System - Product Status
Table 26: Second Generation WiSE CRT System - Product Description
Table 27: WiSE CRT System - Product Status
Table 28: WiSE CRT System - Product Description
Table 29: EBR Systems Inc - Ongoing Clinical Trials Overview
Table 30: WiSE CRT System - Multicenter, Prospective Evaluation of Safety and Performance of the WiCS-LV System in Patients Indicated for Cardiac Resynchronization Therapy
Table 31: WiSE CRT System - Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-responders and Previously Untreatable Patients: SOLVE CRT
Table 32: WiSE CRT System - WiCS-LV Post Market Surveillance Registry
Table 33: IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 34: MRI Defibrillator - Product Status
Table 35: MRI Defibrillator - Product Description
Table 36: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Cardiac Arrhythmia Termination Device - Product Status
Table 38: Cardiac Arrhythmia Termination Device - Product Description
Table 39: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Status
Table 41: Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Description
Table 42: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Atrial Fibrillation Device - Product Status
Table 44: Atrial Fibrillation Device - Product Description
Table 45: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Status
Table 47: Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Description
Table 48: Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Status
Table 49: Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Description
Table 50: MRI Safe CRT-D - Product Status
Table 51: MRI Safe CRT-D - Product Description
Table 52: Medtronic plc - Ongoing Clinical Trials Overview
Table 53: Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Optimizing Pacemaker Therapy Using Multi-point Pacing: The OPT-MPP Study
Table 54: Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Personalized CRT - Multiple Point Pacing Post Approval Study
Table 55: Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Optimizing Pacemaker Therapy Using Multi-point Pacing: The OPT-MPP Study
Table 56: Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Personalized CRT - Multiple Point Pacing Post Approval Study
Table 57: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 58: PARADYM RF SonR CRT-D - Product Status
Table 59: PARADYM RF SonR CRT-D - Product Description
Table 60: NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 61: The Implantable Subcutaneous String Defibrillator (ISSD) - Product Status
Table 62: The Implantable Subcutaneous String Defibrillator (ISSD) - Product Description
Table 63: NewPace Ltd - Ongoing Clinical Trials Overview
Table 64: The Implantable Subcutaneous String Defibrillator (ISSD) - Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment
Table 65: Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Odem Device - Product Status
Table 67: Odem Device - Product Description
Table 68: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Quadra Allure MP CRT-P - MRI Labeling - Product Status
Table 70: Quadra Allure MP CRT-P - MRI Labeling - Product Description
Table 71: TransWorld Med Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Soul Mate - Pacemaker - Product Status
Table 73: Soul Mate - Pacemaker - Product Description
Table 74: Glossary

List of Figures
Figure 1: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
Figure 2: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
Figure 3: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
Figure 4: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
Figure 5: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
Figure 6: Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AI Medical Semiconductor Ltd.
  • Boston Scientific Corp
  • DHS Medical
  • EBR Systems Inc
  • IRadimed Corp
  • Johns Hopkins University
  • LivaNova PLC
  • Mayo Clinic
  • Medtronic plc
  • MicroPort Scientific Corp
  • NewPace Ltd
  • Odem Medical Ltd
  • St. Jude Medical LLC
  • TransWorld Med Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll